Business of Medicine
Feature
Immunotherapy May Be Overused in Dying Patients With Cancer
“There are patients who are getting immunotherapy who shouldn’t,” according to a surgical oncologist from Yale.
From the Journals
Tool Can Help Predict Futile Surgery in Pancreatic Cancer
Researchers evaluate patients with anatomically resectable pancreatic ductal adenocarcinoma who underwent pancreatic resection.
Latest News
Government Accuses Health System of Paying Docs Outrageous Salaries for Patient Referrals
Tennessee-based Erlanger Health System changed its compensation model to entice revenue-generating doctors.
Latest News
SUNY Downstate Emergency Medicine Doc Charged With $1.5M Fraud
EM doc accused of tax fraud, larceny, and falsifying records in case of using business credit card for personal expenses.
News from the FDA/CDC
FDA Approves First Engineered Cell Therapy for a Solid Tumor
This T-cell receptor therapy modifies existing receptors to recognize an array of antigens on the surface of cancer cells.
News from the FDA/CDC
FDA Expands Darzalex Faspro Indication in Myeloma
The approval followed priority review and was based on efficacy and safety findings from the open-label PERSEUS trial.
Commentary
Insurers’ Rules and AI for Preauthorization: ‘Ethically Nuts,’ Says Ethicist
I don’t think I’ve seen anything screwier, from a moral point of view, than the system we have that allows for preauthorization by third-party...
Feature
FDA Calls AstraZeneca’s NSCLC Trial Design Into Question
ODAC: A trial’s design makes it impossible to tell whether patients with resectable NSCLC tumors benefited from durvalumab before surgery, after...
Latest News
A Guide to Eating Healthy While Working in Healthcare
Meal prepping, having healthy snacks on hand, and not striving for perfection may help healthcare workers eat better.
Latest News
Doctor on Death Row: Ahmad Reza Djalali Begins Hunger Strike
Iranian-born doctor renowned for his work in disaster medicine was falsely charged and sentenced to death in Iran.
Feature
Greater Transparency of Oncologists’ Pharma Relationships Needed
Reducing industry payments to hematologists and oncologists could benefit patients, say experts.